"Glucagon" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
Descriptor ID |
D005934
|
MeSH Number(s) |
D06.472.699.587.469.500 D12.644.548.586.469.500
|
Concept/Terms |
Glucagon- Glucagon
- Proglucagon (33-61)
- HG-Factor
- HG Factor
- Hyperglycemic-Glycogenolytic Factor
- Hyperglycemic Glycogenolytic Factor
- Glucagon (1-29)
- Glukagon
|
Below are MeSH descriptors whose meaning is more general than "Glucagon".
Below are MeSH descriptors whose meaning is more specific than "Glucagon".
This graph shows the total number of publications written about "Glucagon" by people in this website by year, and whether "Glucagon" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 4 | 5 |
1995 | 0 | 2 | 2 |
1996 | 0 | 3 | 3 |
1997 | 0 | 3 | 3 |
1998 | 0 | 2 | 2 |
1999 | 0 | 3 | 3 |
2000 | 0 | 1 | 1 |
2001 | 1 | 3 | 4 |
2002 | 1 | 2 | 3 |
2003 | 1 | 1 | 2 |
2004 | 1 | 2 | 3 |
2005 | 1 | 2 | 3 |
2006 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 1 | 3 | 4 |
2009 | 0 | 3 | 3 |
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 0 | 2 | 2 |
2013 | 1 | 3 | 4 |
2014 | 1 | 1 | 2 |
2016 | 2 | 2 | 4 |
2017 | 2 | 2 | 4 |
2018 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2020 | 1 | 1 | 2 |
2021 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucagon" by people in Profiles.
-
Multiple beta cell-independent mechanisms drive hypoglycemia in Timothy syndrome. Nat Commun. 2024 Oct 17; 15(1):8980.
-
Osteocalcin protects islet identity in low-density lipoprotein receptor knockout mice on high-fat diet. J Endocrinol. 2024 Apr 01; 261(1).
-
Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor. J Biol Chem. 2022 05; 298(5):101889.
-
Glucagon blockade restores functional ?-cell mass in type 1 diabetic mice and enhances function of human islets. Proc Natl Acad Sci U S A. 2021 03 02; 118(9).
-
Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors. Transl Psychiatry. 2021 02 16; 11(1):59.
-
Man With Light-headedness and Near Syncope. Ann Emerg Med. 2020 08; 76(2):e9-e10.
-
The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition. Diabetes. 2020 05; 69(5):882-892.
-
The islet-expressed Lhx1 transcription factor interacts with Islet-1 and contributes to glucose homeostasis. Am J Physiol Endocrinol Metab. 2019 03 01; 316(3):E397-E409.
-
Low-Level Insulin Content Within Abundant Non-? Islet Endocrine Cells in Long-standing Type 1 Diabetes. Diabetes. 2019 03; 68(3):598-608.
-
Somatostatin Is Only Partly Required for the Glucagonostatic Effect of Glucose but Is Necessary for the Glucagonostatic Effect of KATP Channel Blockers. Diabetes. 2018 11; 67(11):2239-2253.